Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00492: Variant p.Ser110Leu

Hypoxanthine-guanine phosphoribosyltransferase
Gene: HPRT1
Feedback?
Variant information Variant position: help 110 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Leucine (L) at position 110 (S110L, p.Ser110Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HRH; London. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 110 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 218 The length of the canonical sequence.
Location on the sequence: help DRSIPMTVDFIRLKSYCNDQ S TGDIKVIGGDDLSTLTGKNV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DRSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST-----LTGKNV

                              DGSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Chimpanzee                    DRSIPMTVD-FIRLKSYCND-QSTG-DTKVIGGDDLST---

Mouse                         DRSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Rat                           DRSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Pig                           DRSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Bovine                        DKSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Chicken                       DKSIPMTVD-FIRLKSYCND-QSTG-DIKVIGGDDLST---

Slime mold                    -----VSLE-FMSISSYGAETSSSG-VIRIM--MDLRT---

Baker's yeast                 IRIFAIILSLYEDLNSVGSEVEEVGVKVSRTQWIDYEQCKL

Fission yeast                 IPIQAIGLSLYEELVSDSPE-EVPGLEVKRTQWLDFSTLGM
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 218 Hypoxanthine-guanine phosphoribosyltransferase
Modified residue 103 – 103 N6-acetyllysine
Cross 115 – 115 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
Cross 115 – 115 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate



Literature citations
Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout.
Wilson J.M.; Tarr G.E.; Kelley W.N.;
Proc. Natl. Acad. Sci. U.S.A. 80:870-873(1983)
Cited for: VARIANT HRH LONDON LEU-110; Hypoxanthine-guanine phosphoribosyltransferase. Genetic evidence for identical mutations in two partially deficient subjects.
Davidson B.L.; Chin S.J.; Wilson J.M.; Kelley W.N.; Palella T.D.;
J. Clin. Invest. 82:2164-2167(1988)
Cited for: VARIANT HRH LONDON LEU-110;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.